ZQL-4c exerts anti-tumor effects by specifically targeting SCD1 in triple-negative breast cancer both in vitro and in vivo.

Author: Xiaorui LI ¹ ; Hui CAO ¹ ; Hongna SUN ¹ ; Shuya WANG ¹ ; Xiangyu GUO ¹ ; Shisheng WANG ² ; Tao SUN ¹
Author Information

1. Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institution, Shenyang, Liaoning 110042, China.
2. College of Pharmaceutical Science and Technology, Dalian University of Technology, Dalian, Liaoning 116081, China.
Publication Type:Journal Article
From: Chinese Medical Journal 2025;138(18):2359-2361
CountryChina
Language:English